CoChat

Progestin-only contraceptives: effects on weight

Open access
Lopez, Laureen M, Ramesh, Shanthi, Chen, Mario, Edelman, Alison, Otterness, Conrad, Trussell, James, Helmerhorst, Frans M · 2016 · Cochrane Database of Systematic Reviews
Cited by 230

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Progestin-only contraceptives (POCs) are appropriate for many women who cannot or should not take estrogen. POCs include injectables, intrauterine contraception, implants, and oral contraceptives. Many POCs are long-acting, cost-effective methods of preventing pregnancy. However, concern about weight gain can deter the initiation of contraceptives and cause early discontinuation among users. OBJECTIVES: The primary objective was to evaluate the association between progestin-only contraceptive use and changes in body weight. SEARCH METHODS: Until 4 August 2016, we searched MEDLINE, CENTRAL, POPLINE, LILACS, ClinicalTrials.gov, and ICTRP. For the initial review, we contacted investigators to identify other trials. SELECTION CRITERIA: We considered comparative studies that examined a POC versus another contraceptive method or no contraceptive. The primary outcome was mean change in body weight or mean change in body composition. We also considered the dichotomous outcome of loss or gain of a specified amount of weight. DATA COLLECTION AND ANALYSIS: Two authors extracted the data. Non-randomized studies (NRS) need to control for confounding factors. We used adjusted measures for the primary effects in NRS or the results of matched analysis from paired samples. If the report did not provide adjusted measures for the primary analysis, we used unadjusted outcomes. For RCTs and NRS without adjusted measures, we computed the mean difference (MD) with 95% confidence interval (CI) for continuous variables. For dichotomous outcomes, we calculated the Mantel-Haenszel odds ratio (OR) with 95% CI. MAIN RESULTS: We found 22 eligible studies that included a total of 11,450 women. With 6 NRS added to this update, the review includes 17 NRS and 5 RCTs. By contraceptive method, the review has 16 studies of depot medroxyprogesterone acetate (DMPA), 4 of levonorgestrel-releasing intrauterine contraception (LNG-IUC), 5 for implants, and 2 for progestin-only pills.Comparison groups did not differ significantly for weight change or other body composition measure in 15 studies. Five studies with moderate or low quality evidence showed differences between study arms. Two studies of a six-rod implant also indicated some differences, but the evidence was low quality.Three studies showed differences for DMPA users compared with women not using a hormonal method. In a retrospective study, weight gain (kg) was greater for DMPA versus copper (Cu) IUC in years one (MD 2.28, 95% CI 1.79 to 2.77), two (MD 2.71, 95% CI 2.12 to 3.30), and three (MD 3.17, 95% CI 2.51 to 3.83). A prospective study showed adolescents using DMPA had a greater increase in body fat (%) compared with a group not using a hormonal method (MD 11.00, 95% CI 2.64 to 19.36). The DMPA group also had a greater decrease in lean body mass (%) (MD -4.00, 95% CI -6.93 to -1.07). A more recent retrospective study reported greater mean increases with use of DMPA versus Cu IUC for weight (kg) at years 1 (1.3 vs 0.2), 4 (3.5 vs 1.9), and 10 (6.6 vs 4.9).Two studies reported a greater mean increase in body fat mass (%) for POC users versus women not using a hormonal method. The method was LNG-IUC in two studies (reported means 2.5 versus -1.3; P = 0.029); (MD 1.60, 95% CI 0.45 to 2.75). One also studied a desogestrel-containing pill (MD 3.30, 95% CI 2.08 to 4.52). Both studies showed a greater decrease in lean body mass among POC users. AUTHORS' CONCLUSIONS: We considered the overall quality of evidence to be low; more than half of the studies had low quality evidence. The main reasons for downgrading were lack of randomizations (NRS) and high loss to follow-up or early discontinuation.These 22 studies showed limited evidence of change in weight or body composition with use of POCs. Mean weight gain at 6 or 12 months was less than 2 kg (4.4 lb) for most studies. Those with multiyear data showed mean weight change was approximately twice as much at two to four years than at one year, but generally the study groups did not differ significantly. Appropriate counseling about typical weight gain may help reduce discontinuation of contraceptives due to perceptions of weight gain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd008815.pub4

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 24

  1. Castle WM Sapire KE Howard KA Efficacy and acceptability of injectable medroxyprogesterone: a comparison of 3-monthly and 6-monthly regimens South African Medical Journal 1978 842 5
  2. Salem HT Abdullah KA Shaaban MM Norplant and lactation The Norplant subdermal contraceptive system. Proceedings of the Symposium on Longterm Subdermal Contraceptive Implants; 1984 February 23-24 Assuit, Egypt Assiut University 1984 139 49
  3. Salem HT Salah M Aly MY Thabet AI Shaaban MM Fathalla MF Acceptability of injectable contraceptives in Assiut, Egypt Contraception 1988 697 710 · doi:10.1016/0010-7824(88)90051-0
  4. Sivin I Campodonico I Kiriwat O Holma P Diaz S Wan L The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study Human Reproduction 1998 3371 8 · doi:10.1093/humrep/13.12.3371
  5. Sivin, 1997, Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls, Contraception, 55, 73, 10.1016/S0010-7824(96)00275-2 · doi:10.1016/s0010-7824(96)00275-2
  6. Sule, 2005, Weight changes in clients on hormonal contraceptives in Saria, Nigeria, African Journal of Reproductive Health, 9, 92, 10.2307/3583465 · doi:10.2307/3583465
  7. Tuchman LK Huppert JS Huang B Slap GB Adolescent use of the monthly contraceptive injection Journal of Pediatric and Adolescent Gynecology 2005 255 60 · doi:10.1016/j.jpag.2005.05.004
  8. Barsivala V Virkar K Kulkarni RD Thyroid functions of women taking oral contraceptives Contraception 1974 305 14 · DOI
  9. Berenson, 1997, Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use, American Journal of Obstetrics and Gynecology, 176, 586, 10.1016/S0002-9378(97)70552-0 · doi:10.1016/s0002-9378(97)70552-0
  10. Bonny, 2015, Serum adipocytokines and adipose weight gain: a pilot study in adolescent females initiating depot medroxyprogesterone acetate, Contraception, 92, 298, 10.1016/j.contraception.2015.05.014 · doi:10.1016/j.contraception.2015.05.014
  11. Chen, 2011, [Clinic observation of a levonorgestrel-releasing intrauterine system inserted immediately after artificial abortion], Zhonghua yi xue za zhi, 91, 3176
  12. Dahlberg K Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user International Journal of Gynaecology and Obstetrics 1982 43 8 · doi:10.1016/0020-7292(82)90044-3
  13. Mahgoub, 1980, Body weight and cycle control of injectable contraceptives, Journal of Reproductive Medicine, 24, 119
  14. Gallo, 2016, Association of Progestin Contraceptive Implant and Weight Gain, Obstetrics and Gynecology, 127, 573, 10.1097/AOG.0000000000001289 · doi:10.1097/aog.0000000000001289
  15. Olsson SE Odlind V Johansson ED Sivin I Contraception with NORPLANT implants and NORPLANT-2 implants (two covered rods). Results from a comparative clinical study in Sweden Contraception 1988 61 73 · doi:10.1016/0010-7824(88)90149-7
  16. Zheng SR Zheng HM Qian SZ Sang GW Kaper RF A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant Contraception 1999 1 8 · doi:10.1016/s0010-7824(99)00053-0
  17. American College of Obstetricians and Gynecologists, 2006, ACOG technical bulletin. Use of hormonal contraception in women with coexisting medical conditions
  18. Albright, 2015, HelpDesk answers: do hormonal contraceptives lead to weight gain?, Journal of Family Practice, 64, 371
  19. Bartz, 2011, Injectable contraceptives, 209
  20. Dickerson, 2013, Satisfaction, early removal, and side effects associated with long-acting reversible contraception, Family Medicine, 45, 701
  21. Kohn, 2015, Weight and body mass index among female contraceptive clients, Contraception, 91, 470, 10.1016/j.contraception.2015.02.006 · doi:10.1016/j.contraception.2015.02.006
  22. Raymond, 2011, Progestin-only pills, 237
  23. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
  24. Robinson, 2013, Obesity and hormonal contraceptive efficacy, Womens Health, 9, 453

Cited by

See all 230

Metadata

Authors
Lopez, L. M., Ramesh, S., Chen, M., Edelman, A., Otterness, C., Trussell, J., & Helmerhorst, F. M.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2016-08-28
Volume
2016
Issue
8
Pages
CD008815-CD008815
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W2144592448
Cited by
230
References
90
FWCI
16.02
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.